Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas
- PMID: 27030389
- DOI: 10.1182/blood-2015-12-686550
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas
Abstract
Diffuse large B-cell lymphoma (DLBCL) is one of the most common and aggressive types of B-cell lymphoma. Deregulation of proto-oncogene expression after a translocation, most notably to the immunoglobulin heavy-chain locus (IGH), is one of the hallmarks of DLBCL. Using whole-genome sequencing analysis, we have identified the PD-L1/PD-L2 locus as a recurrent translocation partner for IGH in DLBCL. PIM1 and TP63 were also identified as novel translocation partners for PD-L1/PD-L2 Fluorescence in situ hybridization was furthermore used to rapidly screen an expanded DLBCL cohort. Collectively, a subset of samples was found to be affected by gains (12%), amplifications (3%), and translocations (4%) of the PD-L1/PD-L2 locus. RNA sequencing data coupled with immunohistochemistry revealed that these cytogenetic alterations correlated with increased expression of PD-L1 but not of PD-L2 Moreover, cytogenetic alterations affecting the PD-L1/PD-L2 locus were more frequently observed in the non-germinal center B cell-like (non-GCB) subtype of DLBCL. These findings demonstrate the genetic basis of PD-L1 overexpression in DLBCL and suggest that treatments targeting the PD-1-PD-L1/PD-L2 axis might benefit DLBCL patients, especially those belonging to the more aggressive non-GCB subtype.
© 2016 by The American Society of Hematology.
Similar articles
-
PD-L1 expression is low in large B-cell lymphoma with MYC or double-hit translocation.Hematol Oncol. 2019 Oct;37(4):375-382. doi: 10.1002/hon.2664. Epub 2019 Aug 25. Hematol Oncol. 2019. PMID: 31408531
-
Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma.J Transl Med. 2018 Nov 20;16(1):320. doi: 10.1186/s12967-018-1689-y. J Transl Med. 2018. PMID: 30458835 Free PMC article.
-
UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.Blood. 2016 Mar 24;127(12):1564-74. doi: 10.1182/blood-2015-07-656678. Epub 2015 Dec 23. Blood. 2016. PMID: 26702068 Free PMC article.
-
[Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].Gan To Kagaku Ryoho. 2007 Jul;34(7):975-82. Gan To Kagaku Ryoho. 2007. PMID: 17637530 Review. Japanese.
-
Diffuse large B-cell lymphoma.Pathology. 2018 Jan;50(1):74-87. doi: 10.1016/j.pathol.2017.09.006. Epub 2017 Nov 20. Pathology. 2018. PMID: 29167021 Review.
Cited by
-
PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications.Oncotarget. 2016 Sep 13;7(37):59976-59986. doi: 10.18632/oncotarget.11045. Oncotarget. 2016. PMID: 27527850 Free PMC article.
-
High expression levels of TLR9 and PD-L1 indicates a poor prognosis in patients with angioimmunoblastic T-cell lymphoma: a retrospective study of 88 cases in a single center.J Cancer. 2020 Jan 1;11(1):57-68. doi: 10.7150/jca.37033. eCollection 2020. J Cancer. 2020. PMID: 31892973 Free PMC article.
-
Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinoma.Theranostics. 2018 Nov 10;8(20):5690-5702. doi: 10.7150/thno.28742. eCollection 2018. Theranostics. 2018. PMID: 30555574 Free PMC article.
-
Characterisation of tumor microenvironment and prevalence of CD274/PD-L1 genetic alterations difference in colorectal Cancer.BMC Cancer. 2023 Mar 9;23(1):221. doi: 10.1186/s12885-023-10610-1. BMC Cancer. 2023. PMID: 36894899 Free PMC article.
-
Recent Findings in the Regulation of Programmed Death Ligand 1 Expression.Front Immunol. 2019 Jun 14;10:1337. doi: 10.3389/fimmu.2019.01337. eCollection 2019. Front Immunol. 2019. PMID: 31258527 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials